ConditionBrain & nerves
Acute Motor Axonal Neuropathy (AMAN)
Acute motor axonal neuropathy (AMAN) is a variant of Guillain-Barre syndrome in which the immune system attacks the axons, the long wire-like parts of motor nerves. It causes rapidly progressing weakness, usually starting in the legs, with little or no numbness. It often follows a diarrheal illness caused by Campylobacter jejuni. AMAN is a medical emergency because weakness can reach the breathing muscles. With hospital care and immune treatment, most people recover substantially over months.
Also called: AMAN, axonal Guillain-Barre syndrome, Chinese paralytic syndrome (historical)
At a glance
- What it is
- An autoimmune attack on motor nerve axons; a pure motor form of Guillain-Barre syndrome.
- Common trigger
- Campylobacter jejuni gut infection 1 to 3 weeks earlier; also other infections.
- Key symptoms
- Rapidly rising weakness, reduced or absent reflexes, little sensory loss.
- Where common
- More frequent in China, Japan, Bangladesh, Mexico and other parts of Asia and Latin America than in Europe and North America.
- Treatment
- Intravenous immunoglobulin (IVIG) or plasma exchange, plus intensive supportive care.
When to get help
Call 911 or go to the ER
- Weakness spreading up the legs or into the arms over hours to days: call 911 or your local emergency number
- Shortness of breath, a weak cough, or difficulty swallowing or speaking with new weakness
- A racing or irregular heartbeat, or blood pressure swings, in someone with Guillain-Barre syndrome
See a doctor within a day or two
- New weakness in both legs, difficulty climbing stairs or rising from a chair, within weeks of a diarrheal illness
- Weakness of the face or eye muscles with leg weakness
Book a routine appointment
- Slow recovery or new weakness months after an episode of Guillain-Barre syndrome
How AMAN differs from classic Guillain-Barre syndrome
Guillain-Barre syndrome (GBS) is an umbrella term for acute immune attacks on peripheral nerves. The main forms are:
| Feature | AIDP (demyelinating) | AMAN (axonal) |
|---|---|---|
| Target | The myelin coating of nerves | The axon of motor nerves |
| Sensory symptoms | Common: tingling, numbness, pain | Little or none |
| Common trigger | Various infections | Campylobacter jejuni |
| Antibodies | Usually none identified | Often anti-GM1 or anti-GD1a ganglioside antibodies |
| Nerve tests | Slowed conduction | Reduced motor signal size, normal sensory signals |
| Recovery | Usually steady | Can be fast (if conduction block) or slow (if axons degenerate) |
AIDP is the most common form in North America and Europe. AMAN accounts for a larger share of cases in Asia and Latin America and often affects children and young adults, with summer peaks linked to Campylobacter.
How it happens
Campylobacter jejuni bacteria, a common cause of food poisoning from undercooked poultry, carry sugar molecules on their surface that closely resemble gangliosides on human motor nerves. The immune response to the infection produces antibodies that cross-react with the nerves. This "molecular mimicry" leads to complement activation and damage at the nodes of Ranvier, the gaps in myelin where nerve signals jump. Zika virus, other infections and, rarely, vaccines have also been linked to GBS.
Symptoms
- Muscle weakness that typically begins in the legs and rises to the arms over days, peaking within 4 weeks (often within 2)
- Difficulty walking, climbing stairs or getting up
- Weak hand grip
- Weakness of facial, swallowing or breathing muscles in more severe cases
- Reduced or absent tendon reflexes, though reflexes are occasionally preserved or even brisk in AMAN
- Back or limb pain in some people
- Little or no numbness or tingling, which helps distinguish AMAN from classic GBS
About 1 in 4 people with GBS need a ventilator to support breathing.
Diagnosis
- Neurological exam: symmetrical weakness and reflex changes.
- Nerve conduction studies and EMG: reduced size of motor responses with preserved sensory responses. Repeat studies may be needed to tell reversible conduction failure from true axon loss.
- Lumbar puncture: high protein with a normal white cell count (albuminocytologic dissociation), though it may be normal in the first week.
- Antibody tests: anti-GM1 and anti-GD1a antibodies support AMAN.
- Stool tests for Campylobacter.
- MRI of the spine if needed to rule out spinal cord problems such as transverse myelitis.
- Breathing tests: vital capacity is measured repeatedly to detect respiratory weakness early.
Treatment
Treatment is the same as for other GBS forms and works best when started within the first 2 weeks:
- Intravenous immunoglobulin (IVIG): antibodies from donated blood given over about 5 days.
- Plasma exchange: removes harmful antibodies from the blood over several sessions.
Combining the two does not add benefit. Steroids are not effective in GBS.
Supportive care
- monitoring of breathing, heart rhythm and blood pressure, often in intensive care
- ventilator support if breathing muscles weaken
- prevention of blood clots, pressure sores and infections
- pain control
- early physical and occupational therapy
Recovery and outlook
Recovery varies. Some people with AMAN recover quickly within weeks, because the antibodies blocked conduction without destroying axons. Others recover slowly over months to years as damaged axons regrow at about 1 mm a day. Most people walk independently by 6 to 12 months. Around 1 in 5 have lasting weakness, and fatigue is common. Death occurs in a small percentage, usually from breathing or heart rhythm complications. Relapses are rare.
Older age, rapid onset, severe weakness, the need for a ventilator and preceding diarrhea are linked to slower recovery.
Frequently asked questions
What is acute motor axonal neuropathy?
AMAN is a form of Guillain-Barre syndrome in which the immune system damages the axons of motor nerves. It causes rapidly worsening muscle weakness, usually starting in the legs, without much numbness. It often follows a Campylobacter gut infection.
What causes AMAN?
Most cases follow an infection, especially Campylobacter jejuni from undercooked poultry. The immune system makes antibodies against the bacteria that also recognize molecules on motor nerves, leading to nerve damage.
Can you recover from AMAN?
Yes. Most people recover a large part of their strength. Some improve within weeks, while others need months to years of rehabilitation if axons were badly damaged. Early treatment with IVIG or plasma exchange and intensive rehabilitation give the best chance of recovery.
How is AMAN different from AIDP?
AIDP damages the myelin coating of nerves and usually causes tingling and numbness as well as weakness. AMAN damages the motor axon itself, causes weakness with little sensory loss, is more often linked to Campylobacter, and shows a different pattern on nerve conduction studies.
Sources
This guide was written from current patient and clinical guidance, including:
- National Institute of Neurological Disorders and Stroke: Guillain-Barre syndrome
- CDC: Guillain-Barre syndrome and Campylobacter
- Peripheral Nerve Society and European Academy of Neurology: Guideline on diagnosis and treatment of Guillain-Barre syndrome
- GBS/CIDP Foundation International: GBS variants
- MedlinePlus: Guillain-Barre syndrome